Fig. 6From: A pan-cancer analysis of the oncogenic role of ERCC6LERCC6L was associated with unfavorable outcomes in cancer patients at different clinical stages. Overall survival of cancer patients stratified by ERCC6L expression levels. The patients were classified according to indicated clinical stages of different cancersBack to article page